About this trial
Small Incision Lenticule Extraction (SMILE) was introduced in 2011 using the VISUMAX femtosecond laser (Carl Zeiss Meditec, Jena, Germany). It is designed for correction of myopia and myopic astigmatism.
It involves the creation of a corneal tissue disk called lenticule and its extraction through a minimally invasive incision, utilizing only a femtosecond laser. This enables rapid visual recovery with very little discomfort to the patient.
This observational case series monitors visual and refractive outcomes of myopic correction for more than -7.75 D.
It is to
* gather long-term results and refractive stability * detect rare complications or side-effects * evaluate the efficacy in a large number of patients
Eligibility criteria
Qualifiers
adults
myopia more than -7.75 D
refractive stability more than 1 year
Disqualifiers
corneal irregular astigmatism
ectatic conditions
Trial design
Treatments tested in this trial
- Small Incision Lenticule Extraction (SMILE) with Visumax (Carl Zeiss Meditec, Jena)
Treatment groups
Sponsors and collaborators
Suphi Taneri
Lead sponsor
St. Franziskus Hospital
Sponsor institution